To investigate associations and gene-environment interactions of APOA-IV gene polymorphisms with obesityrelated phenotypes in a Brazilian population. METHODS: A total of 391 individuals (171 men and 220 women) were genotyped for Xbal, Thr347Ser and Gln360His polymorphisms by PCR-RFLP methods. Adjusted body mass index (BMI) and waist circumference (WC) were compared among genotypes/haplotypes by unpaired t-test or analysis of variance. Gene-environment interactions were tested by analysis of variance using a general linear model. RESULTS: Analysis of the APOA-IV gene variants separately showed that X*2 and 347Ser alleles were associated with higher BMI (P ¼ 0.02 for both polymorphisms). Haplotype analysis confirmed this association. For these polymorphisms, the effect on BMI appeared to depend on smoking status (test for interaction, P ¼ 0.007 and 0.02, respectively), the Thr347Ser variant was associated with a BMI increase in smokers only (P ¼ 0.002). At the single-locus level no association was observed between 360His allele and BMI; however, haplotype analyses showed an association of this gene variant and higher BMI. A trend for association with WC (P ¼ 0.05) was observed in male carriers of the 360His allele. The effect of this polymorphism also depended on smoking status (test for interaction, P ¼ 0.018). Nonsmoker male carriers of the 360His allele had a larger waist circumference than homozygotes for the Gln allele (P ¼ 0.003). CONCLUSION: Our data suggest that the APOA-IV gene polymorphisms investigated are associated with obesity-related traits. The effects of X*2 and 347Ser variants on BMI and the 360His variant on waist circumference depended on smoking status.
Introduction
Obesity is a complex multifactorial chronic disease that develops from a complex interaction of genetic factors and the environment. The list of genes and genetic markers associated with human obesity has increased in recent years. 1 The genes relevant to lipoprotein metabolism are among the many potential candidate genes that could be responsible for this genetic variation. Apolipoprotein A-IV (apo AIV) is a plasma glycoprotein synthesized in the enterocytes of the small intestine during fat absorption as a constituent of nascent chylomicrons. Apolipoprotein A-IV enters the circulation on lymph chylomicrons, but thereafter dissociates from their surface, and circulates primarily as a lipid-free protein. 2, 3 Although a broad spectrum of physiologic functions has been proposed for apo A-IV, a preponderance of evidence suggests that its primary biological role is in lipid absorption. 4 More recently, in vivo experiments have provided evidence that this protein may be involved in the inhibition of food intake following the ingestion of fat, modulating body weight gain (reviewed in [5] [6] [7] ). Fujimoto et al 8 demonstrated
that intravenously infused chylous lymph inhibited food intake and that the same chylous lymph treated with apo A-IV antiserum was not effective as an anorectic, showing that apo A-IV was responsible for the effect on food intake. The same group 9 also reported that the administration of apo A-IV via the central nervous system in rats decreased food intake in a dose-dependent manner. Recently, Liu et al 10 demonstrated that apo A-IV and apo A-IV mRNA were present in the rat hypothalamus. Other lines of evidence suggest that the apo A-IV function is related to the potential role of this protein as an enterogastrone, a humoral inhibitor of gastric acid secretion and motility by fat ingestion. 11, 12 This finding seems to be linked to another endocrine mediator of inhibition of gastric motility and gastric acid function, the peptide tyrosine-tyrosine (PYY), which is involved in the stimulation of apo A-IV synthesis and secretion. 13, 14 A third finding supporting the potential role in regulation of food intake by apo A-IV is derived from reports demonstrating that the intestinal levels of apo A-IV were regulated by leptin, 15, 16 a protein with a critical role in energy homeostasis. The gene coding for human apo A-IV was mapped in chromosome 11q23 and is closely linked to the APOA-I and APOC-III genes. 17 Several polymorphisms have been described at this locus. One of the most studied variants is a G to T substitution that causes the change of a glutamine (Gln) residue at position 360 to a histidine (His). Another wellstudied polymorphism is due to an A to T substitution in the first base of codon 347 that changes a threonine (Thr) to a serine (Ser). An XbaI restriction site polymorphism has been detected in the second intron of the APOA-IV gene. These genetic variants have been the subject of several association studies with lipid and lipoproteins, [18] [19] [20] [21] [22] but association studies with body weight and body fat parameters are scarce. 22, 23 In this study, we aim to observe the effects of these APOA-IV polymorphisms on obesity and body fat distribution in subjects randomly sampled from a southern Brazilian community of European ancestry. Because our understanding of how environmental variables interact with genetic factors is incomplete, we also investigated the possibility of an interactive effect between genotype and smoking, alcohol consumption, and physical activity on body weight and body fat distribution.
Material and methods

Subjects
The population sample consisted of 391 subjects of European descent, who were randomly selected from two clinical centers at the Federal University of Rio Grande do Sul. A questionnaire was completed, which included details on drug intake and lifestyle variables such as smoking, physical activity, alcohol consumption, oral contraceptive usage, and menopause status. For smoking status, subjects were classified as nonsmokers, exsmokers (cessation for minimum of 1 y) and current smokers (Z1 cigarette/day). All individuals gave their informed consent prior to the investigation. Exclusion criteria were occasional smoking, secondary hyperlipidemia due to renal, liver or thyroid disease, and diabetes or fasting blood glucose above 6.1 mmol/l.
Anthropometric measurements
The weight and height of subjects were measured in the morning after 12 h fasting. Waist circumference was measured at mid-level between the lower rib margin and the iliac crest. 24 24 Central obesity cut off points were defined as waist circumference over 102 cm for men and 88 cm for women. 24, 25 Biochemical and DNA analyses Blood samples were collected after 12 h fasting subjects. Total cholesterol, HDL cholesterol, triglycerides, and glucose levels were determined at each Clinical Center by standard enzymatic methods. 26 LDL cholesterol was calculated according to Friedewald et al. 27 Genomic DNA was isolated from peripheral blood leucocytes by standard procedures. 28 The three polymorphic sites were analyzed by PCR-RFLP methods as previously described.
29,30
Data analyses Allele frequencies were estimated by gene counting. Both deviation from Hardy-Weinberg equilibrium and allelic distributions between groups were assessed by w 2 tests or, when appropriate, by Fisher's exact test using the GraphPad InStat software version 2.04a (GraphPad Software, San Diego, CA, USA). Haplotypes and linkage disequilibrium (D) were estimated using the ARLEQUIN software (version 2.000).
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D max (D theoretical maximum) and D 0 (the relative magnitude of D as compared to its theoretical maximum, calculated as D/D max ) values were calculated as described by Lewontin. 32 Multiple linear regression analyses were used to adjust BMI and waist circumference for the effects of biological and environmental variables. Age, sex, physical activity, alcohol consumption, cigarette smoking, oral contraceptive usage, and hormone replacement therapy were entered as independent variables in each model. Age was entered as a continuous variable, smoking status as a dummy variable and the others as dichotomous variables. Only variables with a significant contribution were maintained in the final model. BMI was adjusted for the effects of age and gender. For waist circumference distinct models were constructed for each gender. For males, waist circumference was adjusted for the effects of age and physical activity while for females the effects of oral contraceptive usage, alcohol consumption and age were kept in the model. Mean adjusted BMI and waist circumferences were compared among APOA-IV genotypes and haplotypes by ANOVA or Student's t-test.
In order to test the interaction between the APOA-IV genotypes and environmental variables, a factorial delineation of ANOVA was performed using a general linear model procedure. For these analyses exsmokers were excluded and smoking status was entered as a dichotomous variable (nonsmoker, smoker). All statistical analyses were performed using the SPSS 8.0.0 statistical package.
Results
Subjects characteristics, allele frequencies, and linkage disequilibrium Clinical and biological baseline characteristics of the study population are shown in Table 1 . No differences in age, BMI, Association between obesity and APOA-IV gene M Fiegenbaum and MH Hutz and levels of total cholesterol (TC), LDL cholesterol, and triglycerides (TG) were observed between male and female subjects, but as expected, statistically significantly higher HDL cholesterol levels (Po0.001) and smaller waist circumference (Po0.001) were observed in female subjects. Smoking, physical activity, and alcohol consumption were more frequent in male than in female subjects (P ¼ 0.01; P ¼ 0.0008; Po 0.0001, respectively). About 36% of the study population was classified as overweight and 17%, as obese. The APOA-IV XbaI X*2, 347Ser and 360His alleles were observed, respectively, in 18, 17, and 6% of the chromosomes investigated. Genotype distributions were as expected according to Hardy-Weinberg equilibrium (data not shown).
Linkage disequilibrium was observed between the three investigated polymorphic sites: X*2 and 347Ser alleles are almost in complete positive linkage disequilibrium (D 0 ¼ 0.986, Po0.00001). In contrast, 347Ser and 360His alleles never appear in the same haplotype, showing a strong negative linkage disequilibrium (D 0 ¼ À0.984, P ¼ 0.003). There were no significant differences in frequencies of either polymorphism with lipid concentrations (data not shown).
Association with body mass index and waist circumference Adjusted BMI and waist circumferences according to genotypes are presented in Table 2 . Carriers of a X*2 or 347Ser alleles had a significantly higher BMI than noncarrier homozygotes (P ¼ 0.02 for both polymorphisms). There were no significant differences in mean BMI between 360His allele carriers and noncarriers, although heterozygotes for this allele had a somewhat higher BMI (P ¼ 0.11).
No significant association of either polymorphism with waist circumference was seen in this population sample, but a trend for association (P ¼ 0.05) was observed in males carriers of the 360His allele.
The association of BMI and haplotypes derived from the three sites investigated is presented in Figure 1 . Overall, a significant association between BMI and haplotypes was observed (P ¼ 0.003). Pairwise comparisons showed that carriers of at least one copy of the 'X*2-347Ser-360Gln' haplotype had higher BMI levels than homozygotes for the wild-type combination (26.2 vs 24.9, P ¼ 0.003). The presence of one copy of the 'X*1-347Thr-360His' haplotype was also associated with a higher BMI when compared to homozygotes for the most common haplotype (26.6 vs 24.9, P ¼ 0.018). Six individuals had the combination 'X*2-347Ser-360Gln/X*1-347Thr-360His' and were excluded from this analysis. All these associations persisted when BMI and WC were not adjusted for confounding variables.
Interaction with environmental variables
The interaction effects between APOA-IV genotypes and smoking status on BMI are shown in Table 3 . The interaction term genotype*smoking was statistically significant for the XbaI site (P ¼ 0.007) and Thr347Ser variant (P ¼ 0.02). The Thr347Ser effect on BMI was restricted to smokers. Smoking individuals with at least one copy of the Ser allele have a BMI 2.5 kg/m 2 higher than Thr/Thr homozygotes.
The interaction effect between APOA-IV genotypes and smoking on waist circumference was assessed separately in male and female subjects (Table 4) . A significant interaction effect was observed with the Gln360His variant (P ¼ 0.018). Nonsmoker male carriers of the 360His allele had a larger waist Association between obesity and APOA-IV gene M Fiegenbaum and MH Hutz circumference than homozygotes for the Gln allele (P ¼ 0.003). Although smokers with the same genotype showed a smaller WC, it was not statistically different from WC observed in smoker Gln/Gln homozygotes (P ¼ 0.30; Table 4 ). In female subjects, no interaction with smoking was found.
Interactions with alcohol consumption and physical activity were also tested for BMI and WC, but no significant results were observed (data not shown).
Discussion
The study population is mainly of Portuguese ancestry, but Italians, Spaniards, and Germans also contributed to its gene pool. 33 The frequency of the less common alleles of the variants investigated (X*2, 347Ser, and 360His) were similar to those previously reported for southern European populations. [18] [19] [20] [21] [22] 34, 35 The 2001 update of the Human Obesity Gene Map 1 reported two previous studies with evidence for the presence of an association of APOA-IV gene and obesity-related phenotypes. Fisher et al 22 reported that in the 375 controls from the European Atherosclerosis Research Study II, the presence of at least one 347Ser allele was associated with a higher BMI and waist-to-hip ratio, whereas the presence of a 360His allele was associated with lower BMI. Lefevre et al 23 examined the effect of APOA-IV polymorphisms on BMI and percentage body fat in a North American cohort and found that individuals with two copies of the 347Ser allele had a higher BMI and percent body fat when compared with 347Thr/Thr homozygotes. Conversely, the 360His allele was associated with a lower BMI and a lower percent body fat. Our data are consistent with these previous findings of an effect of the Thr347Ser variant on BMI, where the presence of at least one copy of the 347Ser allele was associated with a higher BMI. Haplotype analysis confirmed this association. Therefore, the present study is the third independent replication of an association between Thr347Ser and obesity. For Gln360His polymorphism, single-locus analysis showed that this variant was not associated with BMI. However, haplotype analysis revealed that carriers of haplotypes with the 360His allele had a higher BMI than the subjects with the wild-type combination (26.6 vs 24.9, P ¼ 0.018). This result is probably due to the exclusion of the more consistent effect of the 347Ser allele present among the 360Gln/Gln homozygotes when single-locus analysis was performed. The APOA-IV 360His allele also showed a trend for association with larger waist circumference, but only in male individuals. The contradiction between the results for Gln360His observed in our study and the two previous reports may be due to chance because of the small number of 360His carriers in all investigations. These results seem to suggest that if there is an effect of this polymorphism on body mass or adiposity it is of a lower magnitude than that observed for the Thr347Ser variant. As summarized by Weinberg, 35 the 360His allele displays a higher lipid affinity, is associated with increased postprandial hypertriglyceridemia, a reduced low-density lipoprotein response to dietary cholesterol in the setting of a moderate fat intake, and an increased high-density lipoprotein response to changes in total dietary fat intake. The phenotypic expression of this mutation might require the simultaneous presence of other factors as demonstrated by studies carried out by Campos et al
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, in which differences associated with this mutation were only found in subjects living in urban environments who consumed significantly higher levels of saturated fat and tobacco.
Gene-environment interactions have been reported as a major cause of the apparent inconsistencies between published association studies. Stalenhoef et al 36 stated that the Association between obesity and APOA-IV gene M Fiegenbaum and MH Hutz power of a particular sample to detect an association is crucially dependent on the relative proportions of different subgroups of individuals. Therefore, if the effect of a polymorphism is much greater in smokers than in nonsmokers, a sample composed mainly of nonsmokers will not detect the association with the study trait. The larger waist circumference associated with 360His heterozygotes was confined to nonsmoker males. A non-significant (P ¼ 0.30) WC reduction was observed in male smokers. Notice, however, that these results are based on three 360His carriers.
Moreover, few associations studies have, as yet, been performed between this gene variant and environmental variables. Therefore, further investigations are needed to clarify this issue. Conversely, a higher BMI had been associated with the Thr347Ser and XbaI polymorphisms, but the interaction analyses revealed that this effect was restricted to smokers.
Despite numerous reports of association between smoking and BMI or WC, [37] [38] [39] the knowledge of how daily cigarette smoking may interact with genetic factors is not well Association between obesity and APOA-IV gene M Fiegenbaum and MH Hutz understood. As highlighted by Waterworth et al, 40 when the smoking interactions are interpreted, it is important to remember that lifestyle habits also vary between smokers and nonsmokers. However, it is also obvious that these subgroups are more homogeneous than a sample composed of subjects with different smoking status, a known confounding variable. The potential role of apo A-IV as a satiety factor via effects on the central nervous system and on gastric motility described in rats has not been fully investigated in humans, and whether these effects are modulated by apo A-IV polymorphic isoforms is also an open question. Clearly, more investigations are needed to disclose the mechanisms by which apo A-IV could affect BMI and adiposity.
In conclusion, the results of this study demonstrate that apo A-IV gene polymorphisms were associated with obesityrelated phenotypes assessed by the body mass index and waist circumference. The effects of these gene polymorphisms were, in all cases, dependent on smoking status.
